Biomarker selection and imaging design in cancer: A link with biochemical pathways for imminent engineering. Issue 2 (February 2020)

• Record Type: Journal Article
• Authors: Ali, Joham Surfraz; Ain, Noor ul; Naz, Sania; Zia, Muhammad
• Is Part Of: Heliyon. Volume 6:Issue 2(2020)
• Publication Date: 2020-02
• Subjects: MRI -- Metabolic pathway -- DOPA -- PET -- SPECT -- Cancer -- Imaging -- Cell differentiation -- Metabolomics -- Cancer research -- Medical imaging -- Nuclear medicine -- Biochemistry; Research -- Periodicals; Medical sciences -- Periodicals; Natural history -- Periodicals; Social sciences -- Periodicals; Earth sciences -- Periodicals; Physical sciences -- Periodicals; 507.2
• DOI: 10.1016/j.heliyon.2020.e03340
• Languages: English
• ISSNs: 2405-8440

Abstract

Abstract: Malignant cells reprogram metabolic pathways to meet the demands of growth and proliferation. These altered manners of metabolism are now identified as hallmarks of cancer. Studies have revealed tumor cells alter specific pathways such as glycolysis, fatty acid synthesis and amino acid synthesis to support their proliferation. In this review, we provide a theoretical framework to understand metabolic reprogramming and the mechanisms accompanying distorted metabolism to tumor progression. How these alterations will be assisting in cancer diagnostics and advances in standard techniques in marker identification and imagining are also discussed. Abstract : MRI, Metabolic pathway, DOPA, PET, SPECT, Cancer, Imaging, Cell differentiation, Metabolomics, Cancer research, Medical imaging, Nuclear medicine, Biochemistry.